An improving environment for translational science in Germany has prompted Evotec to launch its latest incubator in the country. This week Evotec SE (Xetra:EVT) announced that it has partnered with Bristol Myers Squibb Co. (NYSE:BMY)...

Greg Covino will step down as CFO and become executive adviser to Novavax Inc. (NASDAQ:NVAX). The vaccine developer hired Troy Morgan as SVP and chief compliance officer and promoted Gale Smith to SVP of discovery...

A Stanford University team led by Crystal Mackall, co-founder of Lyell Immunopharma Inc. and Obsidian Therapeutics Inc., described in Science two ways to prevent or reverse CAR T cell exhaustion. The first is based on a...

Cross-border firm Remiges Ventures will deploy its $95 million second fund to launch start-ups out of Japanese academia and invest in syndicated series A rounds, with a newly launched incubator to help...

Eric Koo will become CEO of Overland ADCT BioPharma (CY) Ltd., the joint venture between Overland Pharmaceuticals and ADC Therapeutics S.A. (NYSE:ADCT) that launched in December. The JV is developing ADC Therapeutics’ loncastuximab tesirine, a pyrrolobenzodiazepine (PBD) dimer-linked...

Growth in China’s biotech sector has driven up demand for executives who can run companies with innovative therapies that can compete on a global stage. BioCentury’s analysis shows that while MNCs remain the primary breeding...

Upon completing the sale of its cancer business to Servier for $1.8 billion up front and up to $200 million in milestones, Agios Therapeutics Inc. (NASDAQ:AGIO) announced plans to repurchase 7.1 million shares, or $344.5...

BeiGene Ltd. (NASDAQ:BGNE; HKEX:6160) promoted SVP Julia Wang to CFO, effective June 30. Wang, who joined BeiGene last June, has held leadership roles in finance at Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), Johnson & Johnson (NYSE:JNJ) and...

John Martin, the visionary leader who transformed Gilead from a fledgling antisense company into an antiviral company whose drugs turned HIV into a manageable condition and cured HCV, passed away Tuesday....

FDA’s approval late Friday of Abecma idecabtagene vicleucel marks the second CAR T cell therapy BMS will bring to market as it continues to fill out its cancer portfolio ahead of revenue losses from...